Silo Pharma
SILO
9 hedge funds and large institutions have $887K invested in Silo Pharma in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 8 closing their positions.
133% more capital invested
Capital invested by funds: $380K → $887K (+$507K)
5.27% more ownership
Funds ownership: 7.93% → 13.19% (+5.3%)
36% less funds holding
Funds holding: 14 → 9 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$240K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$200K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$98.3K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$71.7K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$1.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$64.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22.6K |
| 3 |
Jane Street
New York
|
-$16.1K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.14K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$5.22K |
SILO Hedge Fund Activity: Q2 2026 in Review
9 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q2 2026, worth a combined $887K — up 133% from $380K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SILO and 3 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 6 added.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $240K. The largest seller was Geode Capital Management, exiting entirely with an estimated $64.8K sold.
- 9 institutional investors held Silo Pharma (SILO) as of Q2 2026, down from 14 in Q1 2026.
- Funds reported $887K of Silo Pharma stock for Q2 2026, up 133% quarter-over-quarter.
- 3 funds opened new Silo Pharma positions in Q2 2026 and 8 closed out, a net change of -5 holders.
- The largest Silo Pharma buyer in Q2 2026 was FNY Investment Advisers, an estimated $240K added.
- The largest Silo Pharma seller in Q2 2026 was Geode Capital Management, an estimated $64.8K sold.
Based on aggregated 13F filings for Q2 2026.